Search

Aiden Y. Lee

Examiner (ID: 746, Phone: (571)270-1440 , Office: P/1718 )

Most Active Art Unit
1718
Art Unit(s)
1718, 1713
Total Applications
525
Issued Applications
210
Pending Applications
69
Abandoned Applications
263

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8063381 [patent_doc_number] => 20110245331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'INHIBITORS OF EPOXIDE HYDROLASES FOR THE TREATMENT OF HYPERTENSION' [patent_app_type] => utility [patent_app_number] => 13/113028 [patent_app_country] => US [patent_app_date] => 2011-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11546 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245331.pdf [firstpage_image] =>[orig_patent_app_number] => 13113028 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/113028
INHIBITORS OF EPOXIDE HYDROLASES FOR THE TREATMENT OF HYPERTENSION May 19, 2011 Abandoned
Array ( [id] => 7696124 [patent_doc_number] => 20110230466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'Association of a sinus node if current inhibitor and calcium inhibitor and pharmaceutical compositions containing it' [patent_app_type] => utility [patent_app_number] => 13/068551 [patent_app_country] => US [patent_app_date] => 2011-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1768 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20110230466.pdf [firstpage_image] =>[orig_patent_app_number] => 13068551 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/068551
Association of a sinus node if current inhibitor and calcium inhibitor and pharmaceutical compositions containing it May 12, 2011 Abandoned
Array ( [id] => 7574130 [patent_doc_number] => 20110269786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'TREATMENT OF MAJOR ADVERSE CARDIAC EVENTS AND ACUTE CORONARY SYNDROME IN DIABETIC PATIENTS USING SECRETORY PHOSPHOLIPASE A2 (SPLA2) INHIBITOR OR SPLA2 INHIBITOR COMBINATION THERAPIES' [patent_app_type] => utility [patent_app_number] => 13/098261 [patent_app_country] => US [patent_app_date] => 2011-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19575 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269786.pdf [firstpage_image] =>[orig_patent_app_number] => 13098261 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/098261
TREATMENT OF MAJOR ADVERSE CARDIAC EVENTS AND ACUTE CORONARY SYNDROME IN DIABETIC PATIENTS USING SECRETORY PHOSPHOLIPASE A2 (SPLA2) INHIBITOR OR SPLA2 INHIBITOR COMBINATION THERAPIES Apr 28, 2011 Abandoned
Array ( [id] => 6048666 [patent_doc_number] => 20110207742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'METHOD FOR REDUCTION, STABILIZATION AND PREVENTION OF RUPTURE OF LIPID RICH PLAQUE' [patent_app_type] => utility [patent_app_number] => 13/096477 [patent_app_country] => US [patent_app_date] => 2011-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10362 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207742.pdf [firstpage_image] =>[orig_patent_app_number] => 13096477 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/096477
METHOD FOR REDUCTION, STABILIZATION AND PREVENTION OF RUPTURE OF LIPID RICH PLAQUE Apr 27, 2011 Abandoned
Array ( [id] => 6064566 [patent_doc_number] => 20110201688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'N,N\'-DI-P-BROMOPHENYL GUANIDINE TREATMENT FOR STROKE AT DELAYED TIMEPOINTS' [patent_app_type] => utility [patent_app_number] => 13/090828 [patent_app_country] => US [patent_app_date] => 2011-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5464 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201688.pdf [firstpage_image] =>[orig_patent_app_number] => 13090828 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/090828
N,N'-DI-P-BROMOPHENYL GUANIDINE TREATMENT FOR STROKE AT DELAYED TIMEPOINTS Apr 19, 2011 Abandoned
Array ( [id] => 8056177 [patent_doc_number] => 20120077829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'PARENTERAL SOLUTIONS CONTAINING METOLAZONE' [patent_app_type] => utility [patent_app_number] => 13/076297 [patent_app_country] => US [patent_app_date] => 2011-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2367 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077829.pdf [firstpage_image] =>[orig_patent_app_number] => 13076297 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/076297
PARENTERAL SOLUTIONS CONTAINING METOLAZONE Mar 29, 2011 Abandoned
Array ( [id] => 8697843 [patent_doc_number] => 20130059851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => 'Methods of Diagnosing and Treating Cancer in Patients Having or Developing Resistance to a First Cancer Therapy' [patent_app_type] => utility [patent_app_number] => 13/583056 [patent_app_country] => US [patent_app_date] => 2011-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 26258 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13583056 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/583056
Methods of Diagnosing and Treating Cancer in Patients Having or Developing Resistance to a First Cancer Therapy Mar 8, 2011 Abandoned
Array ( [id] => 6048665 [patent_doc_number] => 20110207741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'Activation of the Renin-Angiotensin System (RAS) and Sudden Cardiac Death' [patent_app_type] => utility [patent_app_number] => 13/032629 [patent_app_country] => US [patent_app_date] => 2011-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19045 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207741.pdf [firstpage_image] =>[orig_patent_app_number] => 13032629 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/032629
Activation of the Renin-Angiotensin System (RAS) and Sudden Cardiac Death Feb 21, 2011 Abandoned
Array ( [id] => 6214388 [patent_doc_number] => 20110136876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'Altering Pharmacokinetics of Pirfenidone Therapy' [patent_app_type] => utility [patent_app_number] => 13/028827 [patent_app_country] => US [patent_app_date] => 2011-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8861 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20110136876.pdf [firstpage_image] =>[orig_patent_app_number] => 13028827 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/028827
Altering Pharmacokinetics of Pirfenidone Therapy Feb 15, 2011 Abandoned
Array ( [id] => 8685108 [patent_doc_number] => 20130053392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'CARBONIC ANHYDRASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/578654 [patent_app_country] => US [patent_app_date] => 2011-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 14132 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13578654 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/578654
CARBONIC ANHYDRASE INHIBITORS Feb 13, 2011 Abandoned
Array ( [id] => 6213877 [patent_doc_number] => 20110136739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'Use of S1P Receptor Agonists in Heart Diseases' [patent_app_type] => utility [patent_app_number] => 13/023423 [patent_app_country] => US [patent_app_date] => 2011-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4820 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20110136739.pdf [firstpage_image] =>[orig_patent_app_number] => 13023423 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/023423
Use of S1P Receptor Agonists in Heart Diseases Feb 7, 2011 Abandoned
Array ( [id] => 6039503 [patent_doc_number] => 20110092552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Treatment and Prevention of Major Adverse Cardiovascular Events or Major Coronary Events by Administering Omega-3 Fatty Acids' [patent_app_type] => utility [patent_app_number] => 12/977111 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6409 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092552.pdf [firstpage_image] =>[orig_patent_app_number] => 12977111 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/977111
Treatment and Prevention of Major Adverse Cardiovascular Events or Major Coronary Events by Administering Omega-3 Fatty Acids Dec 22, 2010 Abandoned
Array ( [id] => 8685066 [patent_doc_number] => 20130053350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'PPAR-SPARING THIAZOLIDINEDIONES AND COMBINATIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 13/515522 [patent_app_country] => US [patent_app_date] => 2010-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 27494 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13515522 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/515522
PPAR-SPARING THIAZOLIDINEDIONES AND COMBINATIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES Dec 14, 2010 Abandoned
Array ( [id] => 6118620 [patent_doc_number] => 20110076293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'TRIPTOLIDE DERIVATIVES FOR MODULATION OF APOPTOSIS AND IMMUNOSUPPRESSION' [patent_app_type] => utility [patent_app_number] => 12/961367 [patent_app_country] => US [patent_app_date] => 2010-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12581 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20110076293.pdf [firstpage_image] =>[orig_patent_app_number] => 12961367 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/961367
TRIPTOLIDE DERIVATIVES FOR MODULATION OF APOPTOSIS AND IMMUNOSUPPRESSION Dec 5, 2010 Abandoned
Array ( [id] => 5937743 [patent_doc_number] => 20110213027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY' [patent_app_type] => utility [patent_app_number] => 12/951494 [patent_app_country] => US [patent_app_date] => 2010-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13189 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20110213027.pdf [firstpage_image] =>[orig_patent_app_number] => 12951494 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/951494
USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY Nov 21, 2010 Abandoned
Array ( [id] => 6016978 [patent_doc_number] => 20110224293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY' [patent_app_type] => utility [patent_app_number] => 12/951471 [patent_app_country] => US [patent_app_date] => 2010-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13195 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224293.pdf [firstpage_image] =>[orig_patent_app_number] => 12951471 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/951471
USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY Nov 21, 2010 Abandoned
Array ( [id] => 8394247 [patent_doc_number] => 20120232087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING SOLID TUMORS AND OTHER MALIGNANCIES' [patent_app_type] => utility [patent_app_number] => 13/509857 [patent_app_country] => US [patent_app_date] => 2010-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13904 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13509857 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/509857
METHODS AND COMPOSITIONS FOR TREATING SOLID TUMORS AND OTHER MALIGNANCIES Nov 16, 2010 Abandoned
Array ( [id] => 7501739 [patent_doc_number] => 20110263601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'METHODS OF TREATING ULCERATIVE COLITIS' [patent_app_type] => utility [patent_app_number] => 12/911011 [patent_app_country] => US [patent_app_date] => 2010-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 32108 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263601.pdf [firstpage_image] =>[orig_patent_app_number] => 12911011 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/911011
METHODS OF TREATING ULCERATIVE COLITIS Oct 24, 2010 Abandoned
Array ( [id] => 5993506 [patent_doc_number] => 20110015159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'METHODS OF INHIBITING VASCULAR PERMEABILITY AND APOPTOSIS' [patent_app_type] => utility [patent_app_number] => 12/894783 [patent_app_country] => US [patent_app_date] => 2010-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8716 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015159.pdf [firstpage_image] =>[orig_patent_app_number] => 12894783 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/894783
Methods of inhibiting vascular permeability and apoptosis Sep 29, 2010 Issued
Array ( [id] => 6033189 [patent_doc_number] => 20110082114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'Methods of Treating Aneurysmal Dilatation, Blood Vessel Wall Weakness and Specifically Abdominal Aortic and Thoracic Aneurysm Using Matrix Metalloprotease-2 Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/895073 [patent_app_country] => US [patent_app_date] => 2010-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16800 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20110082114.pdf [firstpage_image] =>[orig_patent_app_number] => 12895073 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/895073
Methods of Treating Aneurysmal Dilatation, Blood Vessel Wall Weakness and Specifically Abdominal Aortic and Thoracic Aneurysm Using Matrix Metalloprotease-2 Inhibitors Sep 29, 2010 Abandoned
Menu